Strengthening Medical Product Regulation in Low- and Middle-Income Countries

PLoS Medicine

Volumn 9, Issue 10, 2012, Pages

  Preston, Charles ^a   Valdez, Mary Lou ^a   Bond, Katherine ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIETHYLENE GLYCOL; MENINGITIS VACCINE; MENINGOCOCCUS VACCINE;

ARTICLE; CLINICAL RESEARCH; DEATH; DRUG APPROVAL; DRUG COST; DRUG QUALITY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; FUNDING; HOSPITAL PURCHASING; HUMAN; INCOME; INTOXICATION; MEDICOLEGAL ASPECT; POSTMARKETING SURVEILLANCE; PRODUCT SAFETY; SOCIAL STATUS; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; VACCINES;

EID: 84868100722     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001327     Document Type: Article

References (29)

1. WHO (2007) Everybody's business: strengthening health systems to improve health outcomes: WHO's framework for action. Available: http://www.who.int/healthsystems/strategy/everybodys_business.pdf. Accessed 30 August 2012.
2. Global Health Initiative (2012) Guidance for Global Health initiative guidance for country strategies. Available: http://www.ghi.gov/resources/guidance/164904.htm. Accessed 30 August 2012.
3. ICH (2012) ICH official website. Available: http://www.ich.org/. Accessed 30 August 2012.
4. International Medical Device Regulators Forum (2012) International Medical Device Regulators Forum. Available: http://www.imdrf.org/. Accessed 30 August 2012.
5. US Food and Drug Administration (2012) FDA at a glance. Silver Spring (Maryland): FDA.
6. Bogdanich W (6 May 2007) From China to Panama, a trail of poisoned medicine. New York Times.
7. Bogdanich W (14 February 2008) Panama releases report on '06 poisoning. New York Times.
8. US Food and Drug Administration (2011) Pathway to global product safety and quality. Report. Available: http://www.fda.gov/downloads/AboutFDA/CentersOffices/OC/GlobalProductPathway/UCM259845.pdf. Accessed 30 August 2012.
9. Varawalla N, (2007) India's growing clinical research sector: opportunity for global companies. IDrugs 10: 391-394.
10. Kuehn BM, (2011) As production goes global, drug supply faces greater risks to safety, quality. JAMA 306: 811-813.
11. Maïga D, Akanmori BD, Chocarro L, (2009) Regulatory oversight of clinical trials in Africa: progress over the past 5 years. Vaccine 27: 7249-7252.
12. World Health Organization (2011) African vaccine regulatory forum. Available: http://www.who.int/immunization_standards/vaccine_regulation/africa_network/en/index.html. Accessed 30 August 2012.
13. Baylor N (2011) Regulatory systems and global health. In: Proceedings of the Global Health Council Conference. 16 June 2011; Washington (D.C.), United States.
14. World Health Organization (2010) Prequalification of medicines by WHO. Available: http://www.who.int/mediacentre/factsheets/fs278/en/index.html. Accessed 30 August 2012.
15. Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, et al. (2010) Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. JAMA 304: 313-320.
16. Murray J (2011) FDA and PEPFAR In: Proceedings of the Global Health Council Conference. 16 June 2011; Washington (D.C.), United States.
17. Wilson KR, Kohler JC, Ovtcharenko N, (2012) The make or buy debate: considering the limitations of domestic production in Tanzania. Global Health 8: 20.
18. About PEPFAR (2012) US President's Emergency Plan for AIDS Relief. Available: http://www.pepfar.gov/about/index.htm. Accessed 30 August 2012.
19. Management Sciences for Health (2012) Safety of medicines in Sub-Saharan Africa: assessment of pharmacovigilance systems and their performance. Cambridge (Massachusetts): Strengthening Pharmaceutical Systems (SPS) Program, Management Sciences for Health. Available: http://apps.who.int/medicinedocs/en/m/abstract/Js19152en/.
20. Bakare N, Edwards IR, Stergachis A, Pal S, Holmes CB, et al. (2011) Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities. PLoS Med 8: e1001054 doi:10.1371/journal.pmed.1001054.
21. Bishai DM, Champion C, Steele ME, Thompson L, (2011) Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa. Health Aff (Millwood) 30: 1058-1064.
22. Meningitis Vaccine Project (2012) Meningitis Vaccine Project. Available: http://www.meningvax.org/. Accessed 30 August 2012.
23. Institute of Medicine (2012) Ensuring safe foods and medical products through stronger regulatory systems abroad. Washington (D.C.): National Academies Press.
24. African Medicines Regulatory Harmonization Initiative (2012) African Medicines Regulatory Harmonization Initiative. Available: http://www.amrh.org/. Accessed 30 August 2012.
25. Pan American Health Organization (2012) Regional platform on access and innovation in health technologies. Available: http://prais.paho.org/rscpaho/. Accessed 30 August 2012.
26. African Union (2012) Roadmap on shared responsibility and global solidarity for AIDS, TB and malaria response in Africa. Addis Abbaba: African Union.
27. United Nations AIDS (2012) AIDS dependency crisis: sourcing African solutions. Issue Brief. New York: UN AIDS.
28. Sundewall J, Swanson RC, Betigeri A, Sanders D, Collins TE, et al. (2011) Health-systems strengthening: current and future activities. Lancet 377: 1222-1223.
29. Fidler D (2010) The challenges of global health governance. New York: Council on Foreign Relations. Available: http://www.cfr.org/global-governance/challenges-global-health-governance/p22202. Accessed 30 August 2012.